Should you buy CorMedix (CRMD)?
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Engine methodology range
CRMD currently trades below the base anchor, in the lower half of the engine methodology range.
Engine methodology range — mechanically derived from pipeline gate outputs + peer-multiple inputs. Not an analyst price target. JSON-LD emission gated pending counsel review.
What the engine is tracking
- Elite Profitability And Returns→Stable
- Customer Concentration And Earnings Peak↓Deteriorating
- Analyst Target Upside↓Deteriorating
- +2 more pillars — see the Why tab for full reasoning
→ Full pillar scorecard with all 5 pillars + per-dimension breakdown
When this thesis breaks
Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Elite Profitability And Returns
Trip ifNet margin falls below 25% from the current 40%.
- P2Customer Concentration And Earnings Peak
Trip ifTop three customers' share of revenue exceeds 85% from the current 79.0%.
- P3Analyst Target Upside
Trip ifAnalyst target falls below $8.60, leaving less than 10% upside from the current $7.85.
- P4Explosive Revenue Growth
Trip ifQuarterly revenue falls below $53M, the next-quarter estimate, from the current $101.9M.
- P5High Short Interest Squeeze Setup
Trip ifShort interest rises above 25% of float from the current 20%.
How the engine reached this verdict
TrendMatrix's engine output for CorMedix Inc. (CRMD) is STRONG_BUY_WAIT with high conviction, score 7.2/10 at $8.10. The C-path quality+value combination cleared its gates — quality 9.3 and value 8.7 — with 5.02 asymmetric R:R supporting the read.
BUY_NOW requires 8k critical (4.01) to clear OR price pulling back to the entry zone of $7.67 with asymmetry crossing 2.5. The verdict flips to HOLD if overall score deteriorates by ~0.7 from sentiment or technical drift.
On the bull side: V7 flight-to-quality bonus: +0.5 (Q=9.3 in RISK_OFF); Sector modifier (Healthcare): +0.5; Strong overall score: 7.2/10. On the bear side: Concentration risk — Customer: top three customers (79.0%); Earnings expected to decline ~83% (cyclical peak). Active engine warnings: V8: Cyclical trap - fwd PE 23x vs trail 4x (5.9x), V9 Gate Failed: 8K_CRITICAL:4.01.
The engine's suggested entry zone is $7.67, currently 5.5% above entry. Target $13.34, stop $7.13, asymmetric R:R 5.02. The WAIT designation reflects entry-discipline framing — chasing into the current zone compresses asymmetry, which is why the engine separates WAIT from NOW. The engine's sizing output: 2.0% of portfolio at this asymmetry level (high-conviction tier).
For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates CRMD — 10-dimension breakdown →
Bull case
- ▸V7 flight-to-quality bonus: +0.5 (Q=9.3 in RISK_OFF)
- ▸Sector modifier (Healthcare): +0.5
- ▸Strong overall score: 7.2/10
Bear case
- ▸Concentration risk — Customer: top three customers (79.0%)
- ▸Earnings expected to decline ~83% (cyclical peak)